Back to Search Start Over

A Shift in Central Metabolism Accompanies Virulence Activation in Pseudomonas aeruginosa.

Authors :
Perinbam, Kumar
Perinbam, Kumar
Chacko, Jenu V
Kannan, Anerudh
Digman, Michelle A
Siryaporn, Albert
Perinbam, Kumar
Perinbam, Kumar
Chacko, Jenu V
Kannan, Anerudh
Digman, Michelle A
Siryaporn, Albert
Source :
mBio; vol 11, iss 2, e02730-e02718; 2150-7511
Publication Year :
2020

Abstract

The availability of energy has significant impact on cell physiology. However, the role of cellular metabolism in bacterial pathogenesis is not understood. We investigated the dynamics of central metabolism during virulence induction by surface sensing and quorum sensing in early-stage biofilms of the multidrug-resistant bacterium Pseudomonas aeruginosa We established a metabolic profile for P. aeruginosa using fluorescence lifetime imaging microscopy (FLIM), which reports the activity of NADH in live cells. We identified a critical growth transition period during which virulence is activated. We performed FLIM measurements and direct measurements of NADH and NAD+ concentrations during this period. Here, planktonic (low-virulence) and surface-attached (virulence-activated) populations diverged into distinct metabolic states, with the surface-attached population exhibiting FLIM lifetimes that were associated with lower levels of enzyme-bound NADH and decreasing total NAD(H) production. We inhibited virulence by perturbing central metabolism using citrate and pyruvate, which further decreased the enzyme-bound NADH fraction and total NAD(H) production and suggested the involvement of the glyoxylate pathway in virulence activation in surface-attached populations. In addition, we induced virulence at an earlier time using the electron transport chain oxidase inhibitor antimycin A. Our results demonstrate the use of FLIM to noninvasively measure NADH dynamics in biofilms and suggest a model in which a metabolic rearrangement accompanies the virulence activation period.IMPORTANCE The rise of antibiotic resistance requires the development of new strategies to combat bacterial infection and pathogenesis. A major direction has been the development of drugs that broadly target virulence. However, few targets have been identified due to the species-specific nature of many virulence regulators. The lack of a virulence regulator that is conserved across species has presented a fu

Details

Database :
OAIster
Journal :
mBio; vol 11, iss 2, e02730-e02718; 2150-7511
Notes :
application/pdf, mBio vol 11, iss 2, e02730-e02718 2150-7511
Publication Type :
Electronic Resource
Accession number :
edsoai.on1287343129
Document Type :
Electronic Resource